Literature DB >> 15555581

Multifaceted role of galectin-3 on human glioblastoma cell motility.

Charles Debray1, Pierre Vereecken, Nathalie Belot, Peggy Teillard, Jean-Pierre Brion, Massimo Pandolfo, Roland Pochet.   

Abstract

Astrocytic tumors' aggressiveness results from an imbalance between cell proliferation and cell death favoring growth, but also from the propensity of tumor cells to detach from the primary tumor site, migrate, and invade the surrounding parenchyma. Astrocytic tumor progression is known to be associated with an increased expression of galectin-3. We investigated in cell culture how galectin-3 expression affects astrocytoma cell motility. Galectin-3 deficient cells were obtained by stable transfection of the U373 glioblastoma cell line with a specific expression antisense plasmid. Cultured galectin-3 deficient glioblastoma cells showed increased motility potential on laminin and modifications in the cytoskeleton reorganization. In addition, c-DNA microarrays and quantitative immunofluorescence analysis showed that galectin-3 deficient U373 cells have an increased expression of integrins-alpha6 and -beta1, proteins known to be implicated in the regulation of cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555581     DOI: 10.1016/j.bbrc.2004.10.181

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.

Authors:  Tsutomu Kobayashi; Tatsuo Shimura; Toshiki Yajima; Norio Kubo; Kenichiro Araki; Soichi Tsutsumi; Hideki Suzuki; Hiroyuki Kuwano; Avraham Raz
Journal:  Int J Cancer       Date:  2011-03-29       Impact factor: 7.396

2.  Pediatric glioblastoma cells inhibit neurogenesis and promote astrogenesis, phenotypic transformation and migration of human neural progenitor cells within cocultures.

Authors:  Kurt Farrell; Gautam Mahajan; Parthasarathy Srinivasan; Moo-Yeal Lee; Chandrasekhar R Kothapalli
Journal:  Exp Cell Res       Date:  2017-11-10       Impact factor: 3.905

Review 3.  The emerging role of galectins in high-fatality cancers.

Authors:  Cherylane Dubé-Delarosbil; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2017-11-08       Impact factor: 9.261

4.  Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells.

Authors:  Estelle Delamarre; Salma Taboubi; Sylvie Mathieu; Caroline Bérenguer; Véronique Rigot; Jean-Claude Lissitzky; Dominique Figarella-Branger; L'houcine Ouafik; José Luis
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

Review 5.  Systematic review of protein biomarkers of invasive behavior in glioblastoma.

Authors:  Eli T Sayegh; Gurvinder Kaur; Orin Bloch; Andrew T Parsa
Journal:  Mol Neurobiol       Date:  2013-11-24       Impact factor: 5.590

6.  Galectin-3 regulates intracellular trafficking of EGFR through Alix and promotes keratinocyte migration.

Authors:  Wei Liu; Daniel K Hsu; Huan-Yuan Chen; Ri-Yao Yang; Kermit L Carraway; Roslyn R Isseroff; Fu-Tong Liu
Journal:  J Invest Dermatol       Date:  2012-07-12       Impact factor: 8.551

7.  Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells.

Authors:  Lili Qiao; Ning Liang; Jian Xie; Hui Luo; Jingxin Zhang; Guodong Deng; Yupeng Li; Jiandong Zhang
Journal:  Mol Med Rep       Date:  2015-11-10       Impact factor: 2.952

Review 8.  Galectins and gliomas.

Authors:  Marie Le Mercier; Shannon Fortin; Véronique Mathieu; Robert Kiss; Florence Lefranc
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

9.  Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-catenin.

Authors:  Dong Zhang; Zheng-gang Chen; Shao-hua Liu; Zuo-qing Dong; Martin Dalin; Shi-san Bao; Ying-wei Hu; Feng-cai Wei
Journal:  Acta Pharmacol Sin       Date:  2012-10-29       Impact factor: 7.169

10.  Regulation of tumor progression by extracellular galectin-3.

Authors:  Pratima Nangia-Makker; Vitaly Balan; Avraham Raz
Journal:  Cancer Microenviron       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.